{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:41:23Z","timestamp":1792532483179,"version":"4.5.0"},"reference-count":128,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition, primarily characterized by the presence of a limited airflow, due to abnormalities of the airways and\/or alveoli, that often coexists with other chronic diseases such as lung cancer, cardiovascular diseases, and metabolic disorders. Comorbidities are known to pose a challenge in the assessment and effective management of COPD and are also acknowledged to have an important health and economic burden. Local and systemic inflammation have been proposed as having a potential role in explaining the association between COPD and these comorbidities. Considering that the number of patients with COPD is expected to rise, understanding the mechanisms linking COPD with its comorbidities may help to identify new targets for therapeutic purposes based on multi-dimensional assessments.<\/jats:p>","DOI":"10.3390\/jcm13030743","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T11:35:34Z","timestamp":1706614534000},"page":"743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Comorbidities in COPD: Current and Future Treatment Challenges"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-3164","authenticated-orcid":false,"given":"Domenica Francesca","family":"Mariniello","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"D\u2019Agnano","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Cennamo","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Conte","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Quarcio","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Notizia","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Pagliaro","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schiattarella","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Salvi","sequence":"additional","affiliation":[{"name":"U.O.C. Chirurgia Toracica, Azienda Ospedaliera \u201cS.G. Moscati\u201d, 83100 Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-5901","authenticated-orcid":false,"given":"Andrea","family":"Bianco","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7223-7037","authenticated-orcid":false,"given":"Fabio","family":"Perrotta","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cL. Vanvitelli\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1172\/JCI36130","article-title":"The cytokine network in asthma and chronic obstructive pulmonary disease","volume":"118","author":"Barnes","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/thx.2010.155333","article-title":"Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD","volume":"66","author":"Chang","year":"2011","journal-title":"Thorax"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S2213-2600(12)70060-7","article-title":"Chronic obstructive pulmonary disease and comorbidities","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1513\/pats.200404-032MS","article-title":"Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality","volume":"2","author":"Sin","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pulmoe.2018.09.006","article-title":"COPD and Cardiovascular Disease","volume":"25","author":"Conde","year":"2019","journal-title":"Pulmonology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.amjcard.2011.06.059","article-title":"Role of Cigarette Smoking and Gender in Acute Coronary Syndrome Events","volume":"108","author":"Howe","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00229.2018","article-title":"Hemodynamic effects of incremental lung hyperinflation","volume":"315","author":"Cheyne","year":"2018","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic Aspects of Chronic Obstructive Pulmonary Disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"180057","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: Dangerous liaisons?","volume":"27","author":"Rabe","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1378\/chest.09-2029","article-title":"Increased risk of myocardial infarction and stroke following exacerbation of COPD","volume":"137","author":"Donaldson","year":"2010","journal-title":"Chest"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2147\/COPD.S134953","article-title":"Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction","volume":"12","author":"Adrish","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00134-003-1635-0","article-title":"Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease","volume":"29","author":"Baillard","year":"2003","journal-title":"Intensiv. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1183\/09031936.00015807","article-title":"Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation","volume":"31","author":"Brekke","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rmed.2011.10.009","article-title":"Cause-specific mortality adjudication in the UPLIFT\u00ae COPD trial: Findings and recommendations","volume":"106","author":"McGarvey","year":"2012","journal-title":"Respir. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1183\/09031936.04.00120603","article-title":"The TORCH (TOwards a Revolution in COPD Health) survival study protocol","volume":"24","author":"Vestbo","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): A double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1378\/chest.15-0084","article-title":"A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD","volume":"148","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"key":"ref_20","first-page":"CD008989","article-title":"Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease","volume":"2015","author":"Farne","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.2147\/COPD.S146338","article-title":"The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: A quantitative synthesis","volume":"12","author":"Rogliani","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2147\/COPD.S226601","article-title":"The IMPACT Study\u2013Single Inhaler Triple Therapy (FF\/UMEC\/VI) versus FF\/VI and UMEC\/VI in Patients with COPD: Efficacy and Safety in a Japanese Population","volume":"14","author":"Kato","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"00615-2022","DOI":"10.1183\/23120541.00615-2022","article-title":"Triple therapy in COPD: Understanding the data","volume":"9","author":"Suissa","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/hci080","article-title":"Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease","volume":"98","author":"Egred","year":"2005","journal-title":"Qjm Int. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.201208-1565OC","article-title":"Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease","volume":"187","author":"Hermansson","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e020713","DOI":"10.1136\/bmjopen-2017-020713","article-title":"Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: Protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2)","volume":"8","author":"Kunadian","year":"2018","journal-title":"BMJ Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/15412555.2015.1099620","article-title":"Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis","volume":"13","author":"Pavasini","year":"2015","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/HCO.0b013e3283398e53","article-title":"Statins and inflammation: An update","volume":"25","year":"2010","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/srep16461","article-title":"The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: A systematic review and meta-analysis of observational research","volume":"5","author":"Cao","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/thoraxjnl-2014-205795","article-title":"Statin use and exacerbations in individuals with chronic obstructive pulmonary disease","volume":"70","author":"Ingebrigtsen","year":"2014","journal-title":"Thorax"},{"key":"ref_33","first-page":"CD011959","article-title":"Statins versus placebo for people with chronic obstructive pulmonary disease (COPD)","volume":"7","author":"Walsh","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/COPD.S158634","article-title":"Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD","volume":"13","author":"Lai","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1513\/AnnalsATS.201604-317OC","article-title":"Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study","volume":"14","author":"Parikh","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.23736\/S0026-4806.22.07962-9","article-title":"Evolving concepts in COPD and lung cancer: A narrative review","volume":"113","author":"Perrotta","year":"2022","journal-title":"Minerva Medica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/TACG.S20083","article-title":"Genetic evidence linking lung cancer and COPD: A new perspective","volume":"4","author":"Young","year":"2011","journal-title":"Appl. Clin. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1164\/rccm.200811-1757ST","article-title":"An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease","volume":"182","author":"Eisner","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/JOM.0000000000002481","article-title":"Occupational Exposures and Lung Cancer Risk-An Analysis of the CARTaGENE Study","volume":"64","author":"Pasquet","year":"2022","journal-title":"J. Occup. Environ. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12940-023-00976-x","article-title":"The effect of ambient PM2.5 exposure on survival of lung cancer patients after lobectomy","volume":"22","author":"Liu","year":"2023","journal-title":"Environ. Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.rmed.2006.11.011","article-title":"Effects of diesel exhaust particles on human lung epithelial cells: An in vitro study","volume":"101","author":"Mazzarella","year":"2007","journal-title":"Respir. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"srep13502","DOI":"10.1038\/srep13502","article-title":"Susceptibility loci in lung cancer and COPD: Association of IREB2 and FAM13A with pulmonary diseases","volume":"5","author":"Mosor","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TACG.S15758","article-title":"FAM13A locus in COPD is independently associated with lung cancer\u2013evidence of a molecular genetic link between COPD and lung cancer","volume":"4","author":"Young","year":"2010","journal-title":"Appl. Clin. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41435-018-0033-0","article-title":"Correlation between lung cancer and the HHIP polymorphisms of chronic obstructive pulmonary disease (COPD) in the Chinese Han population","volume":"20","author":"Xu","year":"2018","journal-title":"Genes Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1183\/09031936.00033310","article-title":"Chromosome 4q31 locus in COPD is also associated with lung cancer","volume":"36","author":"Young","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/JTO.0000000000000592","article-title":"Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer","volume":"10","author":"Tessema","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12032-017-0900-y","article-title":"Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease","volume":"34","author":"Mahmood","year":"2017","journal-title":"Med. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2147\/COPD.S380732","article-title":"From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis","volume":"17","author":"Qi","year":"2022","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Clere, N., Renault, S., and Corre, I. (2020). Endothelial-to-Mesenchymal Transition in Cancer. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00747"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s12276-020-0439-4","article-title":"Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage","volume":"52","author":"Choi","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc3477","article-title":"Mechanistic links between COPD and lung cancer","volume":"13","author":"Houghton","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13392","DOI":"10.1038\/s41598-017-13888-x","article-title":"Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)","volume":"7","author":"Eapen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Boutilier, A.J., and Elsawa, S.F. (2021). Macrophage Polarization States in the Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136995"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: Key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0032-1304543","article-title":"Severity of Chronic Obstructive Pulmonary Disease and Its Relationship to Lung Cancer Prognosis after Surgical Resection","volume":"61","author":"Suzuki","year":"2012","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1479973120925430","DOI":"10.1177\/1479973120925430","article-title":"Lung cancer resection and postoperative outcomes in COPD: A single-center experience","volume":"17","author":"Roy","year":"2020","journal-title":"Chronic Respir. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.athoracsur.2015.12.057","article-title":"Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease","volume":"101","author":"Bugge","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2018.02.006","article-title":"Targeting immune checkpoints in non small cell lung cancer","volume":"40","author":"Bianco","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jmp2020017","article-title":"Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients","volume":"2","author":"Battiloro","year":"2021","journal-title":"J. Mol. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/17476348.2021.1964362","article-title":"Immune checkpoint inhibitors: A new landscape for extensive stage small cell lung cancer treatment","volume":"15","author":"Bianco","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.chest.2020.04.059","article-title":"Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer","volume":"158","author":"Perrotta","year":"2020","journal-title":"Chest"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"22402","DOI":"10.1038\/s41598-022-26650-9","article-title":"Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer","volume":"12","author":"Polverino","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/ijc.32235","article-title":"Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease","volume":"145","author":"Shin","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.21037\/tlcr-22-667","article-title":"Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: A retrospective cohort study","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.21037\/tlcr-21-214","article-title":"Impact of chronic obstructive pulmonary disease on immune checkpoint inhibitor efficacy in advanced lung cancer and the potential prognostic factors","volume":"10","author":"Zhou","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201704-0795OC","article-title":"Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non\u2013Small Cell Lung Cancer","volume":"197","author":"Mark","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.201706-1110OC","article-title":"Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade","volume":"198","author":"Biton","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100124","DOI":"10.1016\/j.esmoop.2021.100124","article-title":"The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Galvano","year":"2021","journal-title":"ESMO Open"},{"key":"ref_69","first-page":"1","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202108-1943OC","article-title":"Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the \u201cChronic Obstructive Pulmonary Disease-Bronchiectasis Association\u201d","volume":"206","author":"Huang","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/thorax.55.8.635","article-title":"Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care","volume":"55","author":"Guest","year":"2000","journal-title":"Thorax"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in patients with COPD","volume":"140","author":"Sanz","year":"2011","journal-title":"Chest"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chest.2016.11.024","article-title":"Quantitative CT Measures of Bronchiectasis in Smokers","volume":"151","author":"Diaz","year":"2017","journal-title":"Chest"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201208-1518OC","article-title":"Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease","volume":"187","author":"Carrillo","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"00296","DOI":"10.1183\/23120541.00296-2022","article-title":"Multimorbidity in bronchiectasis: A systematic scoping review","volume":"9","author":"Marsland","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Du, Q., Jin, J., Liu, X., and Sun, Y. (2016). Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150532"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study","volume":"151","author":"McDonnell","year":"2017","journal-title":"Chest"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2147\/COPD.S163243","article-title":"High prevalence of bronchiectasis in emphysema-predominant COPD patients","volume":"13","author":"Dou","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/crj.13238","article-title":"Serum biomarkers in patients with stable and exacerbated COPD-bronchiectasis overlap syndrome","volume":"14","author":"Sever","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3390\/nu5104115","article-title":"Adiponectin: An Attractive Marker for Metabolic Disorders in Chronic Obstructive Pulmonary Disease (COPD)","volume":"5","author":"Bianco","year":"2013","journal-title":"Nutrients"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Nigro, E., Mosella, M., Daniele, A., Mallardo, M., Accardo, M., Bianco, A., Perrotta, F., and Scial\u00f2, F. (2023). Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis. Life, 13.","DOI":"10.3390\/life13020444"},{"key":"ref_83","first-page":"977","article-title":"Pulmonary disease by non-tuberculous mycobacteria-clinical management, unmet needs and future perspectives","volume":"11","author":"Larsson","year":"2017","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: State of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review","volume":"82","author":"Oscullo","year":"2022","journal-title":"Drugs"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Oscullo, G., G\u00f3mez-Olivas, J.D., Ingles, M., Mompean, S., Martinez-Perez, R., Suarez-Cuartin, G., la Rosa-Carrillo, D., and Martinez-Garcia, M.A. (2023). Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196417"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","article-title":"Obstructive Sleep Apnea in Adults","volume":"380","author":"Veasey","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201712-2510ST","article-title":"Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement","volume":"197","author":"Malhotra","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-5231(21)00402-0","article-title":"Sleep in Chronic Obstructive Lung Disease","volume":"6","author":"Flenley","year":"1985","journal-title":"Clin. Chest Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.smrv.2016.02.007","article-title":"Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review","volume":"32","author":"Shawon","year":"2016","journal-title":"Sleep Med. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","article-title":"Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome","volume":"182","author":"Marin","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"190064","DOI":"10.1183\/16000617.0064-2019","article-title":"Sleep in chronic respiratory disease: COPD and hypoventilation disorders","volume":"28","author":"McNicholas","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.chest.2020.03.036","article-title":"Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital","volume":"158","author":"Naranjo","year":"2020","journal-title":"Chest"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/japplphysiol.00455.2014","article-title":"The effect of increased lung volume in chronic obstructive pulmonary disease on upper airway obstruction during sleep","volume":"119","author":"Biselli","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0004-9514(14)60203-8","article-title":"The effect of body position on maximal expiratory pressure and flow","volume":"48","author":"Badr","year":"2002","journal-title":"Aust. J. Physiother."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1113\/jphysiol.2012.245159","article-title":"Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea","volume":"591","author":"White","year":"2013","journal-title":"J. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00011-012-0540-9","article-title":"Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat)","volume":"61","author":"Renner","year":"2012","journal-title":"Inflamm. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"220073","DOI":"10.1183\/20734735.0073-2022","article-title":"Overlaps between obstructive sleep apnoea and other respiratory diseases, including COPD, asthma and interstitial lung disease","volume":"18","author":"Bouloukaki","year":"2022","journal-title":"Breathe"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1164\/ajrccm.151.1.7812577","article-title":"Association of chronic obstructive pulmonary disease and sleep apnea syndrome","volume":"151","author":"Chaouat","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"S4253","DOI":"10.21037\/jtd.2018.10.117","article-title":"Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease","volume":"10","author":"McNicholas","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_101","first-page":"277","article-title":"Obstructive sleep apnea and cardiovascular disease: Evidence and underlying mechanisms","volume":"48","author":"Zizi","year":"2009","journal-title":"Minerva Pneumol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15412555.2012.719050","article-title":"Evaluation of Right Ventricular Remodeling Using Cardiac Magnetic Resonance Imaging in Co-Existent Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea","volume":"10","author":"Sharma","year":"2012","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J. Clin. Sleep Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fba.2021-00024","article-title":"A review of therapies for the overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease","volume":"3","author":"Suri","year":"2021","journal-title":"FASEB BioAdvances"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"190080","DOI":"10.1183\/16000617.0080-2019","article-title":"Management of insomnia in sleep disordered breathing","volume":"28","author":"Janssen","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chest.2017.01.026","article-title":"Insomnia and Risk of Cardiovascular Disease","volume":"152","author":"Javaheri","year":"2017","journal-title":"Chest"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5665\/sleep.1698","article-title":"Insomnia in Patients with COPD","volume":"35","author":"Budhiraja","year":"2012","journal-title":"Sleep"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12931-023-02401-w","article-title":"Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs","volume":"24","author":"Luyster","year":"2023","journal-title":"Respir. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Sarber, K.M., and Patil, R.D. (2023). Comorbid Insomnia and Sleep Apnea: Challenges and Treatments. Otolaryngol. Clin. N. Am., in press.","DOI":"10.1016\/j.otc.2023.11.001"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"A2617","DOI":"10.1016\/j.chest.2022.08.2138","article-title":"Respiratory safety of lemborexant in adult and elderly patients with moderate to severe copd","volume":"162","author":"Anderson","year":"2022","journal-title":"Chest"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5664\/jcsm.10788","article-title":"A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea","volume":"20","author":"Cheng","year":"2024","journal-title":"J. Clin. Sleep Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/15412555.2016.1140732","article-title":"The Prevalence of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: A Systematic Review","volume":"13","author":"Beijers","year":"2016","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_113","first-page":"419","article-title":"COPD patients with and without metabolic syndrome: Clinical and functional differences","volume":"9","author":"Almagro","year":"2013","journal-title":"Intern. Emerg. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1378\/chest.09-0393","article-title":"The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity","volume":"136","author":"Watz","year":"2009","journal-title":"Chest"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e4225","DOI":"10.1097\/MD.0000000000004225","article-title":"Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis","volume":"95","author":"Guo","year":"2016","journal-title":"Medicine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11739-011-0700-x","article-title":"COPD and the metabolic syndrome: An intriguing association","volume":"8","author":"Clini","year":"2011","journal-title":"Intern. Emerg. Med."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"R\u00f6pcke, S., Holz, O., Lauer, G., M\u00fcller, M., Rittinghausen, S., Ernst, P., Lahu, G., Elmlinger, M., Krug, N., and Hohlfeld, J.M. (2012). Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046207"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"R1144","DOI":"10.1152\/ajpregu.00442.2014","article-title":"NF-\u03baB-dependent airway inflammation triggers systemic insulin resistance","volume":"309","author":"Cyphert","year":"2015","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thx.2007.086827","article-title":"Obesity and the lung: 5. Obesity and COPD","volume":"63","author":"Franssen","year":"2008","journal-title":"Thorax"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00408-012-9381-0","article-title":"Obesity and Physical Activity in the Daily Life of Patients with COPD","volume":"190","author":"Monteiro","year":"2012","journal-title":"Lung"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"585989","DOI":"10.1155\/2010\/585989","article-title":"Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives","volume":"2010","author":"Tkacova","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Perrotta, F., Nigro, E., Mollica, M., Costigliola, A., D\u2019agnano, V., Daniele, A., Bianco, A., and Guerra, G. (2019). Pulmonary Hypertension and Obesity: Focus on Adiponectin. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040912"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15412555.2020.1857718","article-title":"Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease","volume":"18","author":"Perrotta","year":"2020","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.rmed.2009.08.012","article-title":"Plasma leptin and adiponectin in COPD exacerbations: Associations with inflammatory biomarkers","volume":"104","author":"Krommidas","year":"2010","journal-title":"Respir. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/15412555.2013.808614","article-title":"Respiratory Effects of Insulin Sensitisation with Metformin: A Prospective Observational Study","volume":"11","author":"Sexton","year":"2013","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Schick, M.A., and Schlegel, N. (2022). Clinical Implication of Phosphodiesterase-4-Inhibition. Int J Mol Sci., 23.","DOI":"10.3390\/ijms23031209"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"srep34445","DOI":"10.1038\/srep34445","article-title":"Resveratrol suppresses NTHi-induced inflammation via up-regulation of the negative regulator MyD88 short","volume":"6","author":"Andrews","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/COPD.S350133","article-title":"Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease","volume":"17","author":"Hilberg","year":"2022","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:50:30Z","timestamp":1760104230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":128,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030743"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030743","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]}}}